Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Bionor (Norway)
h-index: 15
Total citations: 1,239
Total papers: 36
Homepage:
https://bionorholding.com/
Recent papers from Bionor (Norway)
Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
PLoS ONE · 2019
Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin
AIDS · 2018
Postvaccination C-Reactive Protein and C5/gp41 732–744 Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x
AIDS Research and Human Retroviruses · 2018
A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model
Virology · 2017
Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial
EBioMedicine · 2017
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
BMC Infectious Diseases · 2017
Correlation of Antibody Responses to a Peptide Antigen gp120-C5 ⁵⁰¹–⁵¹² /gp41 ⁷³²–⁷⁴⁴ with HIV Disease Progression
AIDS Research and Human Retroviruses · 2017
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
SHILAP Revista de lepidopterología · 2015
Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial
PLoS ONE · 2014
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
The Lancet Infectious Diseases · 2014
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
Vaccine · 2013
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scandinavian Journal of Infectious Diseases · 2012
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
AIDS · 2010
Circular CCR5 peptide conjugates and uses thereof (WO2008074895)
Expert Opinion on Therapeutic Patents · 2009
Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens
Expert Opinion on Biological Therapy · 2008
HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
AIDS · 2004
Novel peptide-based HIV-1 immunotherapy
Expert Opinion on Biological Therapy · 2004
Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral Therapy
AIDS Research and Human Retroviruses · 2002